Blood Pressure Management in Vascular Dementia

Primary Treatment Thresholds and Targets

The Canadian Consensus Conference on Dementia recommends antihypertensive therapy for patients with vascular dementia when blood pressure is ≥140/90 mmHg, with a target systolic blood pressure of 130-140 mmHg and diastolic blood pressure <80 mmHg but not <70 mmHg, as supported by the European Society of Cardiology 1, 2
Antihypertensive therapy should be strongly considered for average diastolic blood pressure readings ≥90 mmHg and for average systolic blood pressure readings ≥140 mmHg in patients with cognitive disorders where a vascular contribution is known or suspected, according to the American Heart Association 1, 2

For patients with vascular dementia aged 65-79 years, a target systolic BP of 130-139 mmHg is appropriate, as recommended by the European Society of Hypertension 6
For patients with vascular dementia aged ≥80 years, a more conservative target of 140-150 mmHg systolic is recommended, recognizing that lower targets may not be tolerated in this population, as suggested by the American Geriatrics Society 6, 7

The European Society of Cardiology provides guidance for vascular cognitive impairment, recommending treatment when BP ≥140/90 mmHg, which aligns with broader cardiovascular guidelines while acknowledging the unique considerations in dementia patients 1, 2

The European Society of Cardiology advises against reducing diastolic BP below 70 mmHg, as this may compromise cerebral perfusion, and against reducing systolic BP below 120 mmHg 3, 4, 5
The American Heart Association recommends monitoring for orthostatic hypotension, as standing blood pressure should be measured at each visit, and the absence of normal nocturnal BP decrease is common in vascular dementia and may indicate more severe disease 6, 7

The European Society of Cardiology recommends a RAAS blocker (ACE inhibitor or ARB) as first-line therapy, particularly in the presence of microalbuminuria, albuminuria, proteinuria, or LV hypertrophy, and initiating treatment with a combination of a RAAS blocker with a calcium channel blocker or a thiazide/thiazide-like diuretic 3, 8
The American College of Cardiology suggests starting with low doses and titrating slowly, allowing at least 4 weeks to observe full response, and simplifying regimens with once-daily dosing and single-pill combinations when possible 6, 7

The European Society of Cardiology recommends lifestyle changes, including weight loss if overweight, physical activity, alcohol restriction, sodium restriction (to <100 mmol/day), and increased consumption of fruits, vegetables, and low-fat dairy products, as essential for blood pressure management in vascular dementia 3, 4, 5, 8